Healthcare Services

Gout Therapeutics Market Future Outlook Showing Expansion Toward $5.6 Billion by 2030

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Gout Therapeutics Market During The Forecast Period 2026–2030?

The gout therapeutics market has seen rapid expansion in recent years. Its valuation is predicted to rise from $3.22 billion in 2025 to $3.59 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.6%. The historical surge in this market can be attributed to various factors including alterations in dietary lifestyles, the widespread availability of NSAIDs, an uptick in arthritis diagnoses, the provision of hospital rheumatology services, and progress in the development of pain management drugs.

The gout therapeutics market size is anticipated to experience substantial growth over the forthcoming years. It is projected to expand to $5.6 billion by 2030, achieving this with a compound annual growth rate (CAGR) of 11.8%. This projected increase within the forecast period stems from factors including an expanding aging population, the escalating burden of chronic diseases, advancements in preventive arthritis care, enhanced patient compliance tools, and the development of personalized treatment approaches. Significant trends during the forecast horizon involve the increasing prevalence of lifestyle-related arthritis, a rise in the application of uric acid lowering therapies, the broadening scope of chronic gout management, enhanced awareness concerning early diagnosis, and refinements in long-term disease monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12118&type=smp

What Drivers Are Expected To Influence The Gout Therapeutics Market During The Forecast Period?

The increasing incidence of gout is anticipated to drive the expansion of the gout therapeutics market in the future. Gout is defined as an inflammatory form of arthritis leading to discomfort and inflammation in the joints. This growing prevalence of gout is mainly attributed to obesity and metabolic syndrome, conditions that elevate uric acid concentrations in the bloodstream, resulting in the crystallization of urate within joints. Treatments for gout aim to diminish its frequency and intensity by decreasing uric acid levels, controlling inflammatory responses, and avoiding acute attacks. For example, in June 2025, a publication cited by PubMed Central, a U.S.-based repository for biomedical and life sciences journals, reported that by 2050, age-standardized rates of gout incidence and prevalence are forecasted to climb even higher, highlighting the escalating global impact of the disease. Additionally, in June 2024, as per The National Library of Medicine (NLM), the largest US-based biomedical library, in 2023, the USA recorded 7.9 million cases of co-occurring gout and chronic kidney disease (CKD), a figure anticipated to increase by 29% to 9.6 million by 2035 under the baseline projection. Consequently, the escalating incidence of gout is fueling the expansion of the gout therapeutics market.

What Market Segments Are Evaluated Within The Gout Therapeutics Market?

The gout therapeutics market covered in this report is segmented –

1) By Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroid, Diuretics

2) By Treatment: Xanthine Oxidase Inhibitor, Uricosuria Medication

3) By Disease Condition: Acute, Chronic

4) By End-Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Traditional NSAIDs, Selective COX-2 Inhibitors

2) By Corticosteroid: Oral Corticosteroids, Injectable Corticosteroids

3) By Diuretics: Thiazide Diuretics, Loop Diuretics

Which Trends Are Influencing The Gout Therapeutics Market?

Leading companies in the gout therapeutics market are creating new products, such as urate transporters, which assist in the reabsorption of uric acid from the urine back into the blood. A urate transporter is a protein that aids in moving uric acid (urate) across cell membranes in the kidneys or intestines to manage blood uric acid levels. For instance, in July 2025, Eisai Co. Ltd., a Japan-based pharmaceutical company, introduced URECE (dotinurad), a selective urate transporter 1 (URAT1) inhibitor, which is being commercialized within Eisai’s global specialty care portfolio. URECE is employed to treat hyperuricemia associated with gout, working to decrease serum uric acid levels by boosting its excretion through the kidneys. Moreover, it boasts a favorable safety profile with minimal off-target effects and demonstrates efficacy in patients with mild-to-moderate renal impairment, rendering it appropriate for a diverse group of gout patients.

Who Are The Top Market Participants Influencing The Gout Therapeutics Market?

Major companies operating in the gout therapeutics market are Takeda Pharmaceutical Company Ltd, Novartis AG, AstraZeneca plc, GlaxoSmithKline plc, Merck & Co Inc, Regeneron Pharmaceuticals Inc, Teijin Pharma Ltd, Zydus Group, Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Dr Reddy’s Laboratories Ltd, Amneal Pharmaceuticals Inc, Lupin Limited, Ironwood Pharmaceuticals Inc, Pharvaris NV, Selecta Biosciences Inc, Dyve Biosciences Inc, Arthrosi Therapeutics Inc, Atom Therapeutics Co Ltd, Olatec Therapeutics LLC

Read the full gout therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/gout-therapeutics-global-market-report

Which Region Is Forecast To Lead The Gout Therapeutics Market In Terms Of Market Size?

North America was the largest region in the gout therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gout therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gout Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12118&type=smp

Browse Through More Reports Similar to the Global Gout Therapeutics Market 2026, By The Business Research Company

Chlamydia Trachomatis Ct And Neisseria Gonorrhoeae Ng Testing Global Market Report

https://www.thebusinessresearchcompany.com/report/chlamydia-trachomatis-ct-and-neisseria-gonorrhoeae-ng-testing-global-market-report

Hepatitis Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

Sexual Health Supplement Global Market Report

https://www.thebusinessresearchcompany.com/report/sexual-health-supplement-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795